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Objective HLA-G molecules are non classical HLA class I antigens expressed as 
membrane bound and soluble isoforms (sHLA-G) with a restricted tissue distribution 
and anti-inflammatory functions [1]. Osteoarthritis (OA) is a complex degenerative dis-
ease that affects articular cartilage components and causes damage to the entire joint 
structure including synovium [2]. Since inflammation is involved in the pathogenesis 
of OA, we have analyzed the expression and the production of HLA-G molecules in “in 
vitro” cultured synovial fibroblasts (SFs) from OA patients and control subjects.
Design We have analyzed the levels of sHLA-G1 and HLA-G5 isoforms by immu-
noenzymatic assay (ELISA) in the SFs culture supernatants from six OA patients and six 
control subjects during a 70 day “in vitro” cultures in the presence and in the absence 
of lipopolysaccharide (LPS) or recombinant IL-10 (rIL-10). We have confirmed HLA-G 
modulation by cytofluorimetry and immunofluorescence.
Results Data in ELISA have demonstrated the spontaneous production of sHLA-G 
molecules by both OA and control SFs. The expression has been confirmed by cyto-
fluorimetry and immunofluorescence. OA SFs produce higher levels of sHLA-G1 and 
HLA-G5 molecules during the first 23 days of culture in comparison to control SFs. The 
sHLA-G1 levels further increase over the next 20 days of “in vitro” culture. Atfer LPS 
and rIL-10 treatments, sHLA-G secretion increases in a similar manner in both OA and 
control SFs. 
Conclusions The production of sHLA-G1 molecules, constitutively expressed by 
control and OA SFs, is significantly higher in OA than in control SFs, suggesting that 
these molecules represent a possible molecular target to counteract the synovial joints 
inflammation.
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